国际眼科纵览 ›› 2022, Vol. 46 ›› Issue (6): 516-522.doi: 10.3760/ cma.j.issn.1673-5803.2022.06.008

• 综述 • 上一篇    下一篇

Charles Bonnet综合征及其研究进展

  

  1. 复旦大学附属中山医院眼科,上海200032
  • 出版日期:2022-12-22 发布日期:2023-01-04
  • 通讯作者: 袁非,Email: yuan.fei@zs-hospital.sh.cn

Charles Bonnet syndrome and its research advances

  1. Department of Ophthalmology, Zhongshan Hospital Affiliated to Fudan University, Shanghai 200032, China
  • Online:2022-12-22 Published:2023-01-04
  • Contact: Yuan Fei, Email: yuan.fei@zs-hospital.sh.cn

摘要: Charles Bonnet 综合征(Charles Bonnet syndrome,CBS)是一种视觉受损后出现的视幻觉疾病,患者一般具有完整的自知力,无精神障碍。CBS患病率较低,多见于高龄人群。其发病机制不明,主要假说有释放理论和去传入理论。CBS目前尚无公认的诊断标准,诊断与鉴别诊断多依据临床表现。治疗时以恢复视力为主要目标,首选眼科治疗。(国际眼科纵览,2022, 46:516-522)

关键词: Charles Bonnet 综合征, 视幻觉

Abstract: Charles Bonnet syndrome (CBS) is a kind of visual hallucination disease secondary to visual impairment. Patients generally have complete insight and no mental disorder. The prevalence of CBS is quite low, and it is more common among the elderly. Its pathogenesis remains unclear, but there are well-recognized theories, such as release phenomenon and deafferentation theory. At present, there is no unified diagnostic criteria for CBS, the diagnosis and differential diagnosis are mostly based on clinical features. The main goal of treatment is to restore vision. Ophthalmic treatment is the first choice. (Int Rev Ophthalmol, 2022, 46: 516-522)

Key words: Charles Bonnet syndrome, visual hallucination